|
56
|
195
|
6x27A |
Lon protease proteolytic domain complexed with bortezomib |
|
0
|
6
|
6xbfF |
Structure of ndm-1 in complex with macrocycle inhibitor ndm1i-1g |
|
70
|
229
|
6xbfA |
Structure of ndm-1 in complex with macrocycle inhibitor ndm1i-1g |
|
0
|
6
|
6xbeF |
Structure of ndm-1 in complex with macrocycle inhibitor ndm1i-1f |
|
75
|
228
|
6xciA |
Structure of ndm-1 in complex with macrocycle inhibitor ndm1i-3d |
|
75
|
229
|
6xbeA |
Structure of ndm-1 in complex with macrocycle inhibitor ndm1i-1f |
|
147
|
446
|
6w7jA |
Structure of tdp1 catalytic domain in complex with inhibitor xz635p |
|
148
|
446
|
6w7lA |
Structure of tdp1 catalytic domain in complex with inhibitor xz632p |
|
151
|
446
|
6w7kA |
Structure of tdp1 catalytic domain in complex with inhibitor xz634p |
|
18
|
99
|
6w6tA |
Wt hiv-1 protease in complex with phosphonated umass6 (pu6) |
|
20
|
116
|
6w6rA |
Wt htlv-1 protease in complex with umass6 (um6) |
|
171
|
512
|
7kg7A |
Structure of human parg complexed with parg-292 |
|
176
|
512
|
7kg0A |
Structure of human parg complexed with parg-131 |
|
89
|
315
|
7e35A |
Crystal structure of the sars-cov-2 papain-like protease (plpro) c112s mutant bound to compound s43 |
|
166
|
511
|
7kfpA |
Structure of human parg complexed with parg-119 |
|
111
|
345
|
6m1kA |
Usp7 in complex with a novel inhibitor |
|
168
|
512
|
7kg8A |
Structure of human parg complexed with parg-061 |
|
19
|
116
|
6w6sA |
Wt htlv-1 protease in complex with phosphonated umass6 (pu6) |
|
169
|
512
|
7kg6A |
Structure of human parg complexed with parg-322 |
|
167
|
512
|
7kg1A |
Structure of human parg complexed with parg-002 |
|
160
|
526
|
6wu8A |
Structure of human shp2 in complex with inhibitor iacs-13909 |
|
20
|
116
|
6w6qA |
Wt htlv-1 protease in complex with darunavir (drv) |
|
85
|
306
|
7ltjA |
Room-temperature x-ray structure of sars-cov-2 main protease (3cl mpro) in complex with a non-covalent inhibitor mcule-5948770040 |
|
60
|
178
|
6vivA |
The crystal structure of the 2009 h1n1 pa endonuclease mutant i38t in complex with sj000986192 |
|
135
|
324
|
6l6eA |
Human pde5 catalytic core in complex with avanafil |
|
89
|
304
|
5rl3A |
Pandda analysis group deposition of computational designs of sars-cov-2 main protease covalent inhibitors -- crystal structure of sars-cov-2 main protease in complex with lon-wei-adc59df6-39 (mpro-x3117) |
|
91
|
304
|
5rl1A |
Pandda analysis group deposition of computational designs of sars-cov-2 main protease covalent inhibitors -- crystal structure of sars-cov-2 main protease in complex with lon-wei-adc59df6-27 (mpro-x3113) |
|
88
|
304
|
5rl4A |
Pandda analysis group deposition of computational designs of sars-cov-2 main protease covalent inhibitors -- crystal structure of sars-cov-2 main protease in complex with lon-wei-adc59df6-3 (mpro-x3124) |
|
148
|
368
|
7kbgA |
Structure of human hdac2 in complex with a 2-substituted benzamide inhibitor (compound 20) |
|
137
|
369
|
7kbhA |
Structure of human hdac2 in complex with a 2-substituted benzamide inhibitor (compound 16) |
|
84
|
304
|
7kyuA |
The crystal structure of sars-cov-2 main protease with the formation of cys145-1h-indole-5-carboxylate |
|
90
|
304
|
5rl5A |
Pandda analysis group deposition of computational designs of sars-cov-2 main protease covalent inhibitors -- crystal structure of sars-cov-2 main protease in complex with lon-wei-adc59df6-30 (mpro-x3359) |
|
90
|
304
|
5rl0A |
Pandda analysis group deposition of computational designs of sars-cov-2 main protease covalent inhibitors -- crystal structure of sars-cov-2 main protease in complex with lon-wei-adc59df6-2 (mpro-x3110) |
|
88
|
304
|
5rl2A |
Pandda analysis group deposition of computational designs of sars-cov-2 main protease covalent inhibitors -- crystal structure of sars-cov-2 main protease in complex with lon-wei-adc59df6-26 (mpro-x3115) |
|
18
|
99
|
6uwcA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-08613 |
|
20
|
99
|
6uwbA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-08513 |
|
82
|
306
|
7lb7A |
Joint x-ray/neutron structure of sars-cov-2 main protease (3cl mpro) in complex with telaprevir |
|
137
|
409
|
6umeA |
Crystal structure of human gac in complex with inhibitor upgl00012 |
|
136
|
409
|
6uljA |
Crystal structure of human gac in complex with inhibitor upgl00012 |
|
135
|
409
|
6ul9A |
Crystal structure of human gac in complex with inhibitor upgl00023 |
|
142
|
409
|
6umfA |
Crystal structure of human gac in complex with inhibitor upgl00012 |
|
134
|
409
|
6umdA |
Crystal structure of human gac in complex with inhibitor upgl00012 |
|
142
|
409
|
6ulaA |
Crystal structure of human gac in complex with inhibitor upgl00012 |
|
131
|
409
|
6umcA |
Crystal structure of human gac in complex with inhibitor upgl00012 |
|
130
|
410
|
6ujgA |
Crystal structure of human gac in complex with inhibitor upgl00012 |
|
139
|
409
|
6ujmA |
Crystal structure of human gac in complex with inhibitor upgl00013 |
|
131
|
409
|
6ukbA |
Crystal structure of human gac in complex with inhibitor upgl00012 |
|
121
|
409
|
6uk6A |
Crystal structure of human gac in complex with inhibitor upgl00018 |
|
37
|
177
|
6w5hA |
1.85 a resolution structure of norovirus 3cl protease in complex with inhibitor 5d |
|
37
|
174
|
6w5jA |
1.85 a resolution structure of norovirus 3cl protease in complex with inhibitor 7d |
